2.Quality evaluation of the literature on clinical randomized controlled trials of traditional Chinese medicine for treatment of gastric precancerous lesions in the past 20 years.
Qingqing ZHANG ; Di WU ; Yichen WANG ; Fengyun GUO ; Shengnan YANG ; Ping WANG
Journal of Zhejiang University. Medical sciences 2023;52(5):636-645
OBJECTIVES:
To evaluate the methodological quality of randomized controlled trials (RCTs) of traditional Chinese medicines for the treatment of gastric precancerous lesions in the past 20 years.
METHODS:
The RCTs on traditional Chinese medicines for gastric precancerous lesions were searched from the CNKI, Wanfang database, VIP, PubMed, and Embase from January 2001 to December 2021. The retrieved articles were screened, extracted and evaluated based on the 2010 edition of CONSORT statement, Cochrane Risk of Bias Assessment Scale and additional evaluation indicators.
RESULTS:
A total of 840 papers were included. According to the Cochrane Risk of Bias Assessment Scale, the high risk of bias in the application of randomized methods was 5.95%; the risk of uncertainty for the allocation scheme concealment was 98.93%; the risk of uncertainty for blinding of patients or testers was 98.69%; the risk of uncertainty for blinding of the outcome assessor was 100.00%; the risk of bias for completeness of the outcome data was 2.86%; and the risk of uncertainty for selective reporting was 98.45%. The CONSORT statement evaluating the quality of reporting showed that 100.00% of the RCT articles reported the 8 entries; 36.79% of the literature mentioned the method of randomized sequence generation, but only 27.62% of the literature mentioned who implemented the randomized program, 1.07% of the literature hid the randomized program and 1.31% of the studies were blinded; 36.67% of the literature reported adverse reactions; no literature reported sample size prediction methods. Additional evaluation indicators showed that 17.02% of the studies had ethical approval; 43.81% of the literature specified Chinese medicine evidence; 16.55% of the studies excluded severe heterotrophic hyperplasia; 7.26% of the studies conducted follow-up; and 65.12% of the literature used composite efficacy indicators; 46.67% of the literature applied pathological histological evaluation; 2.62% of the literature applied quality of life evaluation.
CONCLUSIONS
The overall risk of bias in RCTs of traditional Chinese medicines for gastric precancerous lesions is high, and the quality of most of the study reports needs to be improved. In the future, it is necessary to strengthen the study design of RCTs and refer to appropriate traditional Chinese medicines evidence grading standards, select study protocols according to different purposes, provide objective and strong evidence for clinical studies on traditional Chinese medicines, and carry out clinical study design and result reporting suitable for traditional Chinese medicines according to the CONSORT principle.
Humans
;
Medicine, Chinese Traditional
;
Randomized Controlled Trials as Topic
;
Precancerous Conditions/drug therapy*
3.Research progress in establishment of N-methyl-N'-nitro-N-nitroso-guanidine-induced rat model of Precancerous lesion of gastric cancer.
Yu-Ting LU ; Hua-Yi LIU ; Jia-Ju SHANG ; Yi-Jia MAO ; Guang-Ze OUYANG ; Liu YANG
China Journal of Chinese Materia Medica 2021;46(16):4089-4095
Gastric cancer(GC), one of the most common malignancies worldwide, seriously threatens human health due to its high morbidity and mortality. Precancerous lesion of gastric cancer(PLGC) is a critical stage for preventing the occurrence of gastric cancer, and PLGC therapy has frequently been investigated in clinical research. Exploring the proper animal modeling methods is necessary since animal experiment acts as the main avenue of the research on GC treatment. At present, N-methyl-N'-nitro-N-nitroso-guanidine(MNNG) serves as a common chemical inducer for the rat model of GC and PLGC. In this study, MNNG-based methods for modeling PLGC rats in related papers were summarized, and the applications and effects of these methods were demonstrated by examples. Additionally, the advantages, disadvantages, and precautions of various modeling methods were briefly reviewed, and the experience of this research group in exploring modeling methods was shared. This study is expected to provide a reference for the establishment of MNNG-induced PLGC animal model, and a model support for the following studies on PLGC.
Animals
;
Gastric Mucosa
;
Methylnitronitrosoguanidine/toxicity*
;
Precancerous Conditions/chemically induced*
;
Rats
;
Stomach Neoplasms/drug therapy*
8.Effect of three TCM methods for activating blood circulation on early stage apoptosis in rats with chronic atrophic gastritis complicated precancerous lesion.
Yu-Lu ZANG ; Jun-Xiang LI ; Ling-Qun ZHU
Chinese Journal of Integrated Traditional and Western Medicine 2008;28(5):448-450
OBJECTIVETo comparatively study the effects of three TCM methods for activating blood circulation, i.e. in combined with resolving stasis (A), regulating qi (B) and supplementing qi (C), respectively, on early stage cell apoptosis in precancerous lesion of rats with chronic atrophic gastritis (CAG).
METHODSRat model of CAG with precancerous lesion was duplicated by insertion of spring in pylorus and gastric perfusion of high-salt hot paste; and the impact of treatment on cell apoptosis was determined using Annexin V/PI double labeled flow cytometry.
RESULTSAfter being intervened for 12 weeks, the early stage cell apoptosis rate in the natural recovery group was significantly higher than that in the control group (P <0.01); while it lowered more significantly in the three groups receiving TCM therapeutic methods for activating blood circulation, showing significant difference compared with the natural recovery group (P <0.01).
CONCLUSIONThree therapies of activating blood circulation all show inhibitory action on the early stage apoptosis of precancerous lesion in CAG rats, which is possibly one of their action mechanisms for improving or reversing the precancerous lesion.
Animals ; Apoptosis ; drug effects ; Blood Circulation ; drug effects ; Drugs, Chinese Herbal ; therapeutic use ; Gastritis, Atrophic ; complications ; Medicine, Chinese Traditional ; Precancerous Conditions ; complications ; drug therapy ; Qi ; Rats ; Treatment Outcome
9.Photodynamic therapy for malignant and non-malignant diseases: clinical investigation and application.
Yong-gang QIANG ; Xiu-ping ZHANG ; Jian LI ; Zheng HUANG
Chinese Medical Journal 2006;119(10):845-857
Brain Neoplasms
;
drug therapy
;
Cardiovascular Diseases
;
drug therapy
;
Eye Diseases
;
drug therapy
;
Gastrointestinal Neoplasms
;
drug therapy
;
Head and Neck Neoplasms
;
drug therapy
;
Humans
;
Lung Neoplasms
;
drug therapy
;
Neoplasms
;
drug therapy
;
Photochemotherapy
;
Precancerous Conditions
;
drug therapy
;
Skin Diseases
;
drug therapy
;
Skin Neoplasms
;
drug therapy
;
Tooth Diseases
;
drug therapy
;
Urologic Neoplasms
;
drug therapy
10.Progress of diagnosis and treatment of precancerous pathological lesions of mammary cancer.
Ai-li SONG ; Xiao-fei LIU ; Jing-wei LI
Chinese Journal of Integrated Traditional and Western Medicine 2006;26(2):188-190
Prevention and treatment of mammary cancer has been taken into great account recently. "Mutistage developing mode" provides the basis for interrupting and reversing precancerous changes. Traditional Chinese medicine (TCM) has shown effects on precancerous changes through inhibiting angiogenesis, promoting apoptosis, modulating endocrine system and restraining oncogene expression. It was stressed in this review that TCM should study the precancerous change of mammary cancer from the aspects of recognizing the essence of precancerous changes of mammary cancer, formulating the standard of TCM diagnosis and treatment, widening the aim of treatment, and focusing on the mechanism of Chinese herbal medicine in intervening it.
Angiogenesis Inhibitors
;
therapeutic use
;
Animals
;
Apoptosis
;
drug effects
;
Breast Neoplasms
;
diagnosis
;
drug therapy
;
Diagnosis, Differential
;
Drugs, Chinese Herbal
;
therapeutic use
;
Female
;
Humans
;
Medicine, Chinese Traditional
;
Phytotherapy
;
Precancerous Conditions
;
diagnosis
;
drug therapy